JPRN-UMIN000038873已完成未知
Study of dupilumab administration for refractory adulthood asthma - Study of dupilumab administration for refractory adulthood asthma
Sagamihara National Hospital0 个研究点目标入组 30 人开始时间: 2019年12月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The sensitivity to multiple drugs 2. Women who is pregnancy or breast feeding 3. Patients who joins other clinical trial study 4. Patients judged unsuitable as subjects by doctor's judgment
研究者
相似试验
尚未招募
不适用
Clinical efficacy of dupilumab treatment in patients with IgG4-related diseaseDiseases of the musculoskeletal system and connective tissueKCT0006819Ajou University Hospital5
已完成
3 期
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)AsthmaNCT02414854Sanofi1,902
已完成
2 期
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaAsthmaNCT01854047Sanofi776
已完成
3 期
A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal PolypsChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)NCT02912468Sanofi276
已完成
不适用
Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20Multiple myeloma expressing CD20JPRN-UMIN000000531Zenyaku Kogyo Co., Ltd.39